Maglasang, Ronel T.

HRN: 23-95-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
MUPIROCIN 2%, 15G (TUBE)
10/28/2023
11/04/2023
TOPICAL
15g
BID
ABI
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: